Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fumiaki Ueno

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 11, 2005
[Clinical guidelines for the treatment of ulcerative colitis]Fumiaki Ueno
European Journal of Gastroenterology & Hepatology|March 30, 2022
Predictor of primary response to antitumor necrosis factor-α therapy for inflammatory bowel disease: a single-center observational studyAtsushi Yoshida, Koji Kimura, Toshio Morizane, et al.
Journal of Gastroenterology|July 30, 2016
Impact of inflammatory bowel disease on Japanese patients' quality of life: results of a patient questionnaire surveyFumiaki Ueno, Yasuo Nakayama, Eiji Hagiwara, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 13, 2012
[Effect of pharmaceutical care in the diagnosis of Helicobacter pylori infection using 13C-urea breath test]Ryohkan Funakoshi, Haruko Yokoyama, Noriko Kawai, et al.
Inflammatory Intestinal Diseases|June 14, 2021
Serum PR3-ANCA Is a Predictor of Primary Nonresponse to Anti-TNF-α Agents in Patients with Ulcerative ColitisAtsushi Yoshida, Katsuyoshi Matsuoka, Fumiaki Ueno, et al.
Journal of Gastroenterology|October 24, 2012
Evidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in JapanFumiaki Ueno, Toshiyuki Matsui, Takayuki Matsumoto, et al.
Journal of Medical Economics|July 12, 2019
Number needed to treat and cost per remitter for biologic treatments of Crohn's disease in JapanFumiaki Ueno, Michio Doi, Yumi Kawai, et al.
Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica|March 5, 2004
[New preparation method for barium enema: efficacy and administration of oral intestinal lavage solution with gastrointestinal prokinetic agent]Shinichi Futei, Yoshinori Sugino, Sachio Kuribayashi, et al.
Internal Medicine (Tokyo, Japan)|February 3, 2009
Modifiable risk factors for colorectal neoplasms and hyperplastic polypsFumio Omata, William R Brown, Yasuharu Tokuda, et al.
Inflammatory Intestinal Diseases|October 9, 2025
Histological Predictors for Therapeutic Response to Integrin Inhibitors in Patients with Ulcerative ColitisTakuya Kimizuka, Atsushi Yoshida, Fumiaki Ueno, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Nihon Rinsho. Japanese Journal of Clinical Medicine|May 11, 2005
[Clinical guidelines for the treatment of ulcerative colitis]Fumiaki Ueno
European Journal of Gastroenterology & Hepatology|March 30, 2022
Predictor of primary response to antitumor necrosis factor-α therapy for inflammatory bowel disease: a single-center observational studyAtsushi Yoshida, Koji Kimura, Toshio Morizane, et al.
Journal of Gastroenterology|July 30, 2016
Impact of inflammatory bowel disease on Japanese patients' quality of life: results of a patient questionnaire surveyFumiaki Ueno, Yasuo Nakayama, Eiji Hagiwara, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|June 13, 2012
[Effect of pharmaceutical care in the diagnosis of Helicobacter pylori infection using 13C-urea breath test]Ryohkan Funakoshi, Haruko Yokoyama, Noriko Kawai, et al.
Inflammatory Intestinal Diseases|June 14, 2021
Serum PR3-ANCA Is a Predictor of Primary Nonresponse to Anti-TNF-α Agents in Patients with Ulcerative ColitisAtsushi Yoshida, Katsuyoshi Matsuoka, Fumiaki Ueno, et al.
Journal of Gastroenterology|October 24, 2012
Evidence-based clinical practice guidelines for Crohn's disease, integrated with formal consensus of experts in JapanFumiaki Ueno, Toshiyuki Matsui, Takayuki Matsumoto, et al.
Journal of Medical Economics|July 12, 2019
Number needed to treat and cost per remitter for biologic treatments of Crohn's disease in JapanFumiaki Ueno, Michio Doi, Yumi Kawai, et al.
Nihon Igaku Hoshasen Gakkai Zasshi. Nippon Acta Radiologica|March 5, 2004
[New preparation method for barium enema: efficacy and administration of oral intestinal lavage solution with gastrointestinal prokinetic agent]Shinichi Futei, Yoshinori Sugino, Sachio Kuribayashi, et al.
Internal Medicine (Tokyo, Japan)|February 3, 2009
Modifiable risk factors for colorectal neoplasms and hyperplastic polypsFumio Omata, William R Brown, Yasuharu Tokuda, et al.
Inflammatory Intestinal Diseases|October 9, 2025
Histological Predictors for Therapeutic Response to Integrin Inhibitors in Patients with Ulcerative ColitisTakuya Kimizuka, Atsushi Yoshida, Fumiaki Ueno, et al.
Pageof 3